US5196194A
(en)
*
|
1979-05-24 |
1993-03-23 |
The Regents Of The University Of California |
Vaccines containing Hepatitis B S-protein
|
EP0038765B1
(fr)
*
|
1980-04-22 |
1987-09-02 |
Institut Pasteur |
Vaccin contre l'hépatite virale B, procédé et cellules eucaryotes transformées pour la production de ce vaccin
|
US4769238A
(en)
|
1981-08-04 |
1988-09-06 |
The Regents Of The University Of California |
Synthesis of human virus antigens by yeast
|
JPS58146281A
(ja)
*
|
1981-10-19 |
1983-08-31 |
Suntory Ltd |
酵母細胞の形質転換法
|
US4943529A
(en)
*
|
1982-05-19 |
1990-07-24 |
Gist-Brocades Nv |
Kluyveromyces as a host strain
|
AU577259B2
(en)
*
|
1982-08-13 |
1988-09-22 |
Zymogenetics Inc. |
Glycolytic promters for regulated protein expression protease inhibitor
|
DK55685A
(da)
*
|
1985-02-07 |
1986-08-08 |
Nordisk Gentofte |
Enzym eller enzymkompleks med proteolytisk aktivitet
|
US5618697A
(en)
*
|
1982-12-10 |
1997-04-08 |
Novo Nordisk A/S |
Process for preparing a desired protein
|
DE3382547D1
(de)
*
|
1983-01-12 |
1992-05-27 |
Chiron Corp |
Sekretorische expression in eukaryoten.
|
NZ207925A
(en)
*
|
1983-04-25 |
1988-05-30 |
Genentech Inc |
Yeast expression vehicle consisting of a yeast promoter and signal peptide encoding region linked to a heterologus peptide coding region; expression and culture
|
US7198919B1
(en)
|
1983-04-25 |
2007-04-03 |
Genentech, Inc. |
Use of alpha factor sequences in yeast expression systems
|
US4755465A
(en)
*
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
US4859600A
(en)
*
|
1983-04-25 |
1989-08-22 |
Genentech, Inc. |
Recombinant procaryotic cell containing correctly processed human growth hormone
|
US4870008A
(en)
*
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
US5639639A
(en)
*
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
DE3479520D1
(en)
*
|
1983-11-21 |
1989-09-28 |
Ciba Geigy Ag |
Synthesis of tissue plasminogen activator(tpa) by yeast
|
PH23920A
(en)
*
|
1983-12-20 |
1990-01-23 |
Cetus Corp |
Glucoamylase cdna
|
FI841500A0
(fi)
*
|
1984-04-13 |
1984-04-13 |
Valtion Teknillinen |
Foerfarande foer uppbygnande av cellulolytiska jaeststammar.
|
CA1341423C
(en)
|
1984-10-31 |
2003-03-04 |
Paul A. Luciw |
Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
|
US7273695B1
(en)
|
1984-10-31 |
2007-09-25 |
Novartis Vaccines And Diagnostics, Inc. |
HIV immunoassays using synthetic envelope polypeptides
|
US7393949B1
(en)
|
1987-12-24 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Human immunodeficiency virus (HIV) nucleotide sequences
|
US7285271B1
(en)
|
1984-10-31 |
2007-10-23 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenic composition comprising an HIV gag or env polypeptide
|
EP0184575B1
(en)
*
|
1984-12-06 |
1993-04-28 |
Fina Research S.A. |
Transformed yeasts producing lysozyme, plasmids used for this transformation, and uses thereof
|
US4902620A
(en)
*
|
1985-04-25 |
1990-02-20 |
Eli Lilly And Company |
Novel DNA for expression of delta-aminolevulinic acid synthetase and related method
|
EP0226639B1
(en)
*
|
1985-05-29 |
1990-11-14 |
The Green Cross Corporation |
Process for preparing heterogenic protein
|
US5164485A
(en)
*
|
1985-08-20 |
1992-11-17 |
Takeda Chemical Industries, Ltd. |
Modified hepatitis B virus surface antigen P31 and production thereof
|
EP0215594B2
(en)
*
|
1985-08-29 |
2003-10-15 |
Genencor International, Inc. |
Heterologous polypeptide expressed in filamentous fungi, processes for their preparation, and vectors for their preparation
|
JPS62175183A
(ja)
*
|
1985-08-29 |
1987-07-31 |
ジエネンコ− インコ−ポレ−テツド |
繊維状菌類中に発現する異種ポリペプチドとその製造方法及びその製造のためのベクタ−
|
US4937189A
(en)
*
|
1985-10-18 |
1990-06-26 |
Pfizer Inc. |
Expression and secretion of heterologous proteins by Yarrowia lipolytica transformants
|
CA1295567C
(en)
*
|
1988-07-25 |
1992-02-11 |
Lawrence T. Malek |
Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces
|
GB8530631D0
(en)
|
1985-12-12 |
1986-01-22 |
Ciba Geigy Ag |
Thrombin inhibitors
|
US5024941A
(en)
*
|
1985-12-18 |
1991-06-18 |
Biotechnica International, Inc. |
Expression and secretion vector for yeast containing a glucoamylase signal sequence
|
US4935349A
(en)
*
|
1986-01-17 |
1990-06-19 |
Zymogenetics, Inc. |
Expression of higher eucaryotic genes in aspergillus
|
US5766912A
(en)
|
1986-03-17 |
1998-06-16 |
Novo Nordisk A/S |
Humicola lipase produced in aspergillus
|
US5536661A
(en)
*
|
1987-03-10 |
1996-07-16 |
Novo Nordisk A/S |
Process for the production of protein products in aspergillus
|
FR2599753B1
(fr)
*
|
1986-06-05 |
1989-12-08 |
Sanofi Sa |
Sequence d'adn composite et son application pour la production de l'hormone de croissance
|
GB8615701D0
(en)
*
|
1986-06-27 |
1986-08-06 |
Delta Biotechnology Ltd |
Stable gene integration vector
|
JPH0616716B2
(ja)
*
|
1986-10-14 |
1994-03-09 |
塩野義製薬株式会社 |
酵母におけるヒトpstiの製造法
|
MY103358A
(en)
*
|
1987-04-15 |
1993-06-30 |
Novartis Ag |
Process for the production of protiens.
|
US5610034A
(en)
*
|
1987-04-29 |
1997-03-11 |
Alko Group Ltd. |
Immunoglobulin production by trichoderma
|
JP2791418B2
(ja)
*
|
1987-12-02 |
1998-08-27 |
株式会社ミドリ十字 |
異種蛋白質の製造方法、組換えdna、形質転換体
|
CA1340772C
(en)
*
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
JPH01240191A
(ja)
*
|
1988-02-16 |
1989-09-25 |
Green Cross Corp:The |
酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現
|
US5149544A
(en)
*
|
1989-11-13 |
1992-09-22 |
Research Corporation Technologies, Inc. |
Method of inhibiting progenitor cell proliferation
|
US6172039B1
(en)
|
1990-04-16 |
2001-01-09 |
Apex Bioscience, Inc. |
Expression of recombinant hemoglobin and hemoglobin variants in yeast
|
AU652576B2
(en)
*
|
1990-09-13 |
1994-09-01 |
Duke University |
Expression of G protein coupled receptors in yeast
|
AU8740491A
(en)
*
|
1990-09-28 |
1992-04-28 |
Protein Engineering Corporation |
Proteinaceous anti-dental plaque agents
|
US5364930A
(en)
*
|
1990-10-16 |
1994-11-15 |
Northwestern University |
Synthetic C1q peptide fragments
|
US5932483A
(en)
*
|
1990-10-16 |
1999-08-03 |
Northwestern University |
Synthetic peptide and its uses
|
FR2669931B1
(fr)
*
|
1990-11-29 |
1995-03-31 |
Transgene |
Nouveaux variants derives des interferons-alpha et leur procede de production.
|
AU656353B2
(en)
*
|
1990-11-29 |
1995-02-02 |
Institut National De La Recherche Agronomique (Inra) |
New variants derived from interferons of type I, production process thereof and their applications
|
CA2058820C
(en)
*
|
1991-04-25 |
2003-07-15 |
Kotikanyad Sreekrishna |
Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells
|
US5330901A
(en)
*
|
1991-04-26 |
1994-07-19 |
Research Corporation Technologies, Inc. |
Expression of human serum albumin in Pichia pastoris
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US5538863A
(en)
*
|
1993-07-01 |
1996-07-23 |
Immunex Corporation |
Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
JP3763924B2
(ja)
*
|
1997-03-17 |
2006-04-05 |
フクダ電子株式会社 |
超音波診断装置
|
US6265186B1
(en)
|
1997-04-11 |
2001-07-24 |
Dsm N.V. |
Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
|
AU7466998A
(en)
|
1997-04-14 |
1998-11-11 |
Byron E. Anderson |
Method and material for inhibiting complement
|
FR2768743B1
(fr)
|
1997-09-23 |
2001-09-14 |
Bio Merieux |
Procede de lyse de micro-organisme
|
GB2338236B
(en)
|
1998-06-13 |
2003-04-09 |
Aea Technology Plc |
Microbiological cell processing
|
US6268178B1
(en)
|
1999-05-25 |
2001-07-31 |
Phage Biotechnology Corp. |
Phage-dependent super-production of biologically active protein and peptides
|
US6890730B1
(en)
|
1999-12-10 |
2005-05-10 |
The Salk Institute |
Sequence and method for increasing protein expression in cellular expression systems
|
US6946134B1
(en)
|
2000-04-12 |
2005-09-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6905688B2
(en)
|
2000-04-12 |
2005-06-14 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6358733B1
(en)
|
2000-05-19 |
2002-03-19 |
Apolife, Inc. |
Expression of heterologous multi-domain proteins in yeast
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
EP1522590B1
(en)
|
2000-06-28 |
2009-08-26 |
Glycofi, Inc. |
Methods for producing modified glycoproteins
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US7083787B2
(en)
*
|
2000-11-15 |
2006-08-01 |
Globeimmune, Inc. |
Yeast-dendritic cell vaccines and uses thereof
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
PT1463751E
(pt)
|
2001-12-21 |
2013-08-26 |
Human Genome Sciences Inc |
Proteínas de fusão de albumina
|
EP1463752A4
(en)
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
ALBUMIN FUSION PROTEINS
|
WO2004022593A2
(en)
*
|
2002-09-09 |
2004-03-18 |
Nautilus Biotech |
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
|
US7439042B2
(en)
*
|
2002-12-16 |
2008-10-21 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis C infection
|
KR101164509B1
(ko)
*
|
2002-12-16 |
2012-07-10 |
글로브이뮨 |
면역 요법으로서의 효모계 백신
|
US8343502B2
(en)
*
|
2002-12-16 |
2013-01-01 |
Globeimmune, Inc. |
Yeast-based vaccines as immunotherapy
|
EP1594530A4
(en)
|
2003-01-22 |
2006-10-11 |
Human Genome Sciences Inc |
HYBRID PROTEINS OF ALBUMIN
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
AU2004263900A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Arriva Pharmaceuticals, Inc. |
Methods of protein production in yeast
|
HUE033349T2
(en)
*
|
2003-10-22 |
2017-11-28 |
Keck Graduate Inst |
Procedures for the Synthesis of Heteromultimer Polypeptides in Yeast Using an Hagloid Mating Strategy
|
SI1684719T1
(sl)
*
|
2003-11-14 |
2012-07-31 |
Baxter Int |
Sestavki alfa antitripsina in postopki zdravljenja ob uporabi takih sestavkov
|
CA2551131A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Centocor, Inc. |
Novel recombinant proteins with n-terminal free thiol
|
WO2005068489A1
(ja)
|
2004-01-20 |
2005-07-28 |
Juridical Foundation The Chemo-Sero Therapeutic Research Institute |
2価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
|
MX2007004662A
(es)
|
2004-10-18 |
2007-11-23 |
Globeimmune Inc |
Terapia basada en levaduras para infeccion cronica por hepatitis c.
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
US20070105768A1
(en)
*
|
2004-11-10 |
2007-05-10 |
Rajiv Nayar |
Dry recombinant human alpha 1-antitrypsin formulation
|
BRPI0613025A2
(pt)
*
|
2005-07-11 |
2010-12-14 |
Globeimmune Inc |
composiÇço para reduzir a resistÊncia a um agente, mÉtodo para a preparaÇço de um veÍculo de levedura e uso da composiÇço
|
US20070172503A1
(en)
*
|
2005-12-13 |
2007-07-26 |
Mycologics,Inc. |
Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
|
JP2009531068A
(ja)
*
|
2006-03-27 |
2009-09-03 |
グローブイミューン,インコーポレイテッド |
Ras変異並びにこれに関連する組成物及び方法
|
JP2008174489A
(ja)
*
|
2007-01-18 |
2008-07-31 |
Nitto Denko Corp |
微生物とペプチド性薬物を含む新規製剤
|
DK2121013T3
(en)
|
2007-02-02 |
2015-01-19 |
Globeimmune Inc |
Methods for preparing yeast-based vaccines
|
RU2505313C2
(ru)
*
|
2007-03-19 |
2014-01-27 |
Глоубиммьюн, Инк. |
Композиции и способы направленного устранения мутационного ускользания в направленной терапии рака
|
EP2331125A4
(en)
|
2008-09-19 |
2013-03-27 |
Globeimmune Inc |
IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS
|
WO2010121180A1
(en)
|
2009-04-17 |
2010-10-21 |
Globeimmune, Inc. |
Combination immunotherapy compositions against cancer and methods
|
WO2011032119A1
(en)
|
2009-09-14 |
2011-03-17 |
The Regents Of The University Of Colorado |
Modulation of yeast-based immunotherapy products and responses
|
EP2651439B1
(en)
|
2010-12-17 |
2018-09-19 |
Globeimmune, Inc. |
Compositions and methods for the treatment or prevention of human adenovirus-36 infection
|
CN103476426B
(zh)
|
2011-02-12 |
2021-08-10 |
全球免疫股份有限公司 |
用于慢性乙型肝炎病毒感染的基于酵母的治疗剂
|
EP2685995B1
(en)
|
2011-03-17 |
2017-05-03 |
Globeimmune, Inc. |
Yeast-brachyury immunotherapeutic compositions
|
AU2012271625B2
(en)
|
2011-06-14 |
2017-05-18 |
Globeimmune, Inc. |
Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
|
CN109010809A
(zh)
|
2011-08-17 |
2018-12-18 |
全球免疫股份有限公司 |
酵母-muc1免疫治疗组合物及其用途
|
US9653272B2
(en)
|
2012-06-26 |
2017-05-16 |
Biodesix, Inc. |
Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies
|
EP2872644B1
(en)
|
2012-07-12 |
2017-07-12 |
UAB Baltymas |
Generation of native recombinant secreted human endoplasmic reticulum chaperones by using their native signal sequences in yeast expression systems
|
SG10201707608QA
(en)
|
2013-03-19 |
2017-10-30 |
Globeimmune Inc |
Yeast-based immunotherapy for chordoma
|
TWI626948B
(zh)
|
2013-03-26 |
2018-06-21 |
環球免疫公司 |
治療或預防人類免疫缺乏病毒感染之組合物及方法
|
US10226522B2
(en)
|
2013-08-30 |
2019-03-12 |
Globeimmune, Inc. |
Compositions and methods for the treatment or prevention of tuberculosis
|
JP2017507182A
(ja)
*
|
2014-02-24 |
2017-03-16 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
Tmem100ペプチド及びその変異体、並びに疾患又は状態の処置又は予防におけるそれらの使用
|
CN113419058B
(zh)
|
2014-04-11 |
2025-04-01 |
全球免疫股份有限公司 |
基于酵母的免疫疗法和i型干扰素敏感性
|
EP3331552B1
(en)
|
2015-08-03 |
2021-01-27 |
Globeimmune, Inc. |
Modified yeast-brachyury immunotherapeutic compositions
|
CN119818663A
(zh)
|
2018-05-15 |
2025-04-15 |
全球免疫公司 |
用于诱导细胞免疫应答的重组酵母裂解物
|
US12161777B2
(en)
|
2020-07-02 |
2024-12-10 |
Davol Inc. |
Flowable hemostatic suspension
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
JP2024500994A
(ja)
|
2020-12-28 |
2024-01-10 |
デボル,インコーポレイテッド |
タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料
|
CN113549639B
(zh)
*
|
2021-07-21 |
2022-07-29 |
云南中烟工业有限责任公司 |
一种降低烟叶总蛋白及烟气苯酚含量的调控基因
|